Deutsche Bank AG lowered its stake in Trupanion, Inc. (NASDAQ:TRUP - Free Report) by 10.1% in the 1st quarter, according to its most recent filing with the SEC. The fund owned 120,979 shares of the financial services provider's stock after selling 13,567 shares during the period. Deutsche Bank AG owned 0.28% of Trupanion worth $4,509,000 as of its most recent SEC filing.
A number of other institutional investors have also modified their holdings of TRUP. Wells Fargo & Company MN grew its position in shares of Trupanion by 44.1% during the 4th quarter. Wells Fargo & Company MN now owns 15,798 shares of the financial services provider's stock valued at $761,000 after buying an additional 4,836 shares during the last quarter. Russell Investments Group Ltd. grew its position in shares of Trupanion by 41.8% during the 4th quarter. Russell Investments Group Ltd. now owns 9,172 shares of the financial services provider's stock valued at $442,000 after buying an additional 2,706 shares during the last quarter. Invesco Ltd. grew its position in shares of Trupanion by 122.0% during the 4th quarter. Invesco Ltd. now owns 226,652 shares of the financial services provider's stock valued at $10,925,000 after buying an additional 124,549 shares during the last quarter. Raymond James Financial Inc. bought a new stake in shares of Trupanion during the 4th quarter valued at about $593,000. Finally, Gabelli Funds LLC bought a new stake in shares of Trupanion during the 4th quarter valued at about $217,000.
Analyst Ratings Changes
Several research analysts have commented on TRUP shares. Lake Street Capital decreased their target price on shares of Trupanion from $65.00 to $60.00 and set a "buy" rating for the company in a research report on Friday, May 2nd. Cantor Fitzgerald raised shares of Trupanion to a "hold" rating in a research note on Wednesday, August 13th. Stifel Nicolaus increased their target price on shares of Trupanion from $41.00 to $45.00 and gave the company a "hold" rating in a research note on Friday, August 8th. Finally, Piper Sandler increased their target price on shares of Trupanion from $62.00 to $67.00 and gave the company an "overweight" rating in a research note on Friday, August 8th. Three research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company's stock. Based on data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus target price of $54.17.
Read Our Latest Report on Trupanion
Trupanion Price Performance
TRUP stock traded up $0.15 on Friday, hitting $47.88. 97,958 shares of the company's stock traded hands, compared to its average volume of 598,369. Trupanion, Inc. has a 1-year low of $31.00 and a 1-year high of $57.90. The stock has a market cap of $2.06 billion, a price-to-earnings ratio of 184.72 and a beta of 1.78. The stock has a fifty day moving average of $50.99 and a 200-day moving average of $44.08. The company has a current ratio of 1.69, a quick ratio of 1.69 and a debt-to-equity ratio of 0.32.
Trupanion (NASDAQ:TRUP - Get Free Report) last issued its quarterly earnings results on Thursday, August 7th. The financial services provider reported $0.22 EPS for the quarter, beating the consensus estimate of ($0.03) by $0.25. The business had revenue of $353.56 million during the quarter, compared to the consensus estimate of $346.73 million. Trupanion had a net margin of 0.81% and a return on equity of 3.31%. The firm's quarterly revenue was up 12.3% on a year-over-year basis. During the same quarter in the prior year, the firm earned ($0.14) EPS. Trupanion has set its FY 2025 guidance at EPS. Q3 2025 guidance at EPS. On average, analysts forecast that Trupanion, Inc. will post 0.13 EPS for the current fiscal year.
Insider Activity at Trupanion
In related news, COO John R. Gallagher sold 4,000 shares of the company's stock in a transaction that occurred on Thursday, May 29th. The shares were sold at an average price of $47.90, for a total value of $191,600.00. Following the completion of the sale, the chief operating officer owned 26,966 shares in the company, valued at approximately $1,291,671.40. This represents a 12.92% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO Fawwad Qureshi sold 2,534 shares of the company's stock in a transaction that occurred on Thursday, May 29th. The shares were sold at an average price of $48.31, for a total transaction of $122,417.54. Following the completion of the sale, the chief financial officer owned 3,545 shares of the company's stock, valued at approximately $171,258.95. This trade represents a 41.68% decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders sold 7,562 shares of company stock valued at $361,430. 5.42% of the stock is owned by insiders.
Trupanion Profile
(
Free Report)
Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.
Recommended Stories

Before you consider Trupanion, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Trupanion wasn't on the list.
While Trupanion currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.